Given uncertainty over COVID-19 vaccines, S. Korea looks into Russian option
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
While the Pfizer vaccine was supposed to be the first COVID-19 vaccine to be administered in South Korea, the shipment of enough doses for 60,000 people may be delayed past the middle of February.
South Korea’s disease control authorities plan to review various vaccines — including one made by Russia — in order to respond to the possible delay in the vaccine supply and the spread of coronavirus variants.
AstraZeneca, which has contracted with the South Korean government to provide vaccine doses for 10 million people, is supposed to fulfill its first shipment of vaccine, enough to inoculate 750,000 people, on Feb. 24.
Before the Pfizer vaccine can reach South Korea, “a contract first needs to be concluded between Pfizer and the COVAX Facility,” said Jeong Eun-kyeong, commissioner of the Korea Disease Control and Prevention Agency (KDCA), during a press briefing on Feb. 8.
The COVAX Facility is an international body that arranges joint purchases of COVID-19 vaccines.
“After that, the supply schedule might be adjusted a little because of government procedures. Some of the remaining procedures are beyond our control,” Jeong said.
It was initially thought that the supply of Pfizer vaccines that Korea has arranged through the COVAX Facility (117,000 doses, enough for 60,000 people) might arrive as early as mid-February. But Jeong’s comments suggest that the shipment might arrive later than expected, depending on how long it takes Pfizer to conclude contract negotiations with the COVAX Facility and shipping deliberations with the South Korean government.
But the KDCA emphasized that “the COVAX Facility has never officially changed the delivery schedule since it informed the South Korean government last month that [the vaccine] would arrive in mid-February.”
“We need to keep securing more vaccines because of uncertainty surrounding virus variants and delays in the vaccine supply. We’re looking into all vaccine candidates, including the Russian-made Sputnik V,” Jeong said.
Jeong said that Seoul is keeping its options open, though it isn’t currently discussing anything specific with the Russians, such as order size or schedule. Previously, the KDCA had said it wasn’t considering the option of ordering a Russian-made vaccine.
On Feb. 10, a review board at South Korea’s Ministry of Food and Drug Safety will make the final decision about whether to approve the AstraZeneca vaccine. There are questions about the vaccine’s efficacy for the elderly.
“The vaccines will arrive on Feb. 24, and we expect that all preparations will be thoroughly completed prior to that to enable inoculation to commence immediately,” said Prime Minister Chung Sye-kyun during a Q&A session on education, society and culture at the National Assembly.
After his remarks, the KDCA explained that Chung had been referring to the AstraZeneca vaccine.
By Choi Ha-yan, staff reporter
Please direct comments or questions to [english@hani.co.kr]
Copyright © 한겨레신문사 All Rights Reserved. 무단 전재, 재배포, AI 학습 및 활용 금지
- “이모 집 욕조서 숨진 10살 여자 어린이는 물고문까지 당했다”
- 졸업식 앞두고 해직된 선생님들도 발걸음…교정에 울린 ‘지금 이순간’
- ‘환경부 블랙리스트’ 김은경 전 장관 징역 2년6개월…법정 구속
- 백운규 영장 기각에 당혹스러운 검찰…윗선 수사 차질 불가피
- 설 연휴 내내 3월 같은 포근한 봄날씨…밤에는 살짝 추워요
- 전파 속도 빨라지는 변이 바이러스…하루만에 26명 추가
- [미얀마 속보] 경찰 허공에 경고 사격…시민들 나흘째 대규모 시위
- 26일 아스트라제네카 백신 접종 시작…요양병원·시설 먼저
- “서울 하늘에 드론카 1천여대 떠다닐 것”이라니 ‘머선129’
- “나경영 괜찮다”는 나경원…박영선만 공격하는 오세훈, 왜?